Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 233Lung Neoplasms 96Adenocarcinoma of Lung 39Colorectal Neoplasms 21Adenocarcinoma, Bronchiolo-Alveolar 19Neoplasms 18Small Cell Lung Carcinoma 13Non-Squamous Non-Small Cell Lung Cancer 13Brain Neoplasms 13Neoplasm Metastasis 10Ovarian Neoplasms 9Pleural Effusion, Malignant 8Breast Neoplasms 8Stomach Neoplasms 7Pancreatic Neoplasms 7Meningeal Carcinomatosis 7Mesothelioma 6Melanoma 6Endometrial Neoplasms 5Uterine Cervical Neoplasms 4Triple Negative Breast Neoplasms 4Rectal Neoplasms 4Non-squamous Non-small Cell Lung Cancer 4Carcinoma, Renal Cell 4Squamous Cell Carcinoma of Head and Neck 3Recurrence 3Non-small Cell Lung Cancer Metastatic 3Mesothelioma, Malignant 3Esophageal Neoplasms 3Colonic Neoplasms 3

Interventions

Pemetrexed 1Paclitaxel 1One-Lung Ventilation 1NOV 002 1Carboplatin 1Bevacizumab 1Anesthesia, General 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pericardial Effusion × Bevacizumab × Thoracic × Clear all
NCT02054052 2019-03-29

Intrapleural Bevacizumab Injection for Malignant Effusion in Lung Cancer

Guangzhou Medical University

Phase 2 Completed
22 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Pericardial Effusion, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡